Literature for epoxomicin (T01.012 inhibitor)

Summary Structure Literature

(Topics flags: S Structure, A Assay, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2013

Gotze,S., Bose,A., Abele,D., Sokolova,I.M. and Saborowski,R.
Pitfalls in invertebrate proteasome assays
J Exp Biol216, 1351-1354. PubMed Europe PubMed DOI A I

2012

Wei,D., Lei,B., Tang,M. and Zhan,C.G.
Fundamental reaction pathway and free energy profile for inhibition of proteasome by epoxomicin
J Am Chem Soc134, 10436-10450. PubMed Europe PubMed DOI I

2004

Glenn,R.J., Pemberton,A.J., Royle,H.J., Spackman,R.W., Smith,E., Jennifer Rivett,A. and Steverding,D.
Trypanocidal effect of alpha',beta'-epoxyketones indicates that trypanosomes are particularly sensitive to inhibitors of proteasome trypsin-like activity
Int J Antimicrob Agents24, 286-289. PubMed Europe PubMed DOI I
[YEAR:29-11-2004]Groll,M. and Huber,R.
Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach
Biochim Biophys Acta1695, 33-44. PubMed Europe PubMed DOI V I

2002

Groll,M., Nazif,T., Huber,R. and Bogyo,M.
Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome
Chem Biol9, 655-662. PubMed Europe PubMed DOI S I

2001

Kozlowski,L., Stoklosa,T., Omura,S., Wojcik,C., Wojtukiewicz,M.Z., Worowski,K. and Ostrowska,H.
Lactacystin inhibits cathepsin A activity in melanoma cell lines
Tumour Biol22, 211-215. PubMed Europe PubMed DOI I

2000

[YEAR:16-2-2000]Groll,M., Kim,K.B., Kairies,N., Huber,R. and Crews,C.M.
Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of alpha',beta'-epoxyketone proteasome inhibitors
J Am Chem Soc122, 1237-1238. DOI S I

1999

[YEAR:6-12-1999]Kim,K.B., Myung,J., Sin,N. and Crews,C.M.
Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency
Bioorg Med Chem Lett9, 3335-3340. PubMed Europe PubMed I